• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过实时PCR对HLA-DRA进行定量的初步结果:一种识别脓毒症中免疫抑制的有前景的方法。

Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis.

作者信息

Cajander Sara, Bäckman Anders, Tina Elisabet, Strålin Kristoffer, Söderquist Bo, Källman Jan

出版信息

Crit Care. 2013 Oct 6;17(5):R223. doi: 10.1186/cc13046.

DOI:10.1186/cc13046
PMID:24093602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4057202/
Abstract

INTRODUCTION

Reduced monocyte human leukocyte antigen (mHLA)-DR surface expression in the late phase of sepsis is postulated as a general biomarker of sepsis-induced immunosuppression and an independent predictor of nosocomial infections.

METHODS

Fifty-nine patients with sepsis and blood culture growing pathogenic bacteria were studied. Blood samples were collected at day 1 or 2 after admission, for measurement of mHLA-DR by flow cytometry and mRNA expression of HLA-DRA and class II transactivator (CIITA) by qRT-PCR. Blood samples from blood donors were used as controls (n = 30).

RESULTS

A significant reduced expression of mHLA-DR, HLA-DRA, and CIITA was seen in septic patients compared with controls. HLA-DRA mRNA level in whole blood was highly correlated with surface expression of mHLA-DR.

CONCLUSIONS

Patients with sepsis display a diminished expression of HLA-DR at the monocyte surface as well as in the gene expression at the mRNA level. The mRNA expression level of HLA-DRA monitored by qRT-PCR correlates highly with surface expression of HLA-DR and appears to be a possible future biomarker for evaluation of immunosuppression in sepsis.

摘要

引言

脓毒症晚期单核细胞人类白细胞抗原(mHLA)-DR表面表达降低被认为是脓毒症诱导免疫抑制的一般生物标志物以及医院感染的独立预测指标。

方法

对59例脓毒症且血培养出致病细菌的患者进行研究。入院后第1天或第2天采集血样,通过流式细胞术检测mHLA-DR,通过qRT-PCR检测HLA-DRA和II类反式激活因子(CIITA)的mRNA表达。以献血者的血样作为对照(n = 30)。

结果

与对照组相比,脓毒症患者中mHLA-DR、HLA-DRA和CIITA的表达显著降低。全血中HLA-DRA mRNA水平与mHLA-DR的表面表达高度相关。

结论

脓毒症患者单核细胞表面的HLA-DR表达以及mRNA水平的基因表达均降低。通过qRT-PCR监测的HLA-DRA mRNA表达水平与HLA-DR的表面表达高度相关,似乎是未来评估脓毒症免疫抑制的一种可能的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/0bf0bd0d29eb/cc13046-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/4390032d2310/cc13046-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/34cfd4f426fe/cc13046-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/0bf0bd0d29eb/cc13046-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/4390032d2310/cc13046-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/34cfd4f426fe/cc13046-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1f3/4057202/0bf0bd0d29eb/cc13046-3.jpg

相似文献

1
Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis.通过实时PCR对HLA-DRA进行定量的初步结果:一种识别脓毒症中免疫抑制的有前景的方法。
Crit Care. 2013 Oct 6;17(5):R223. doi: 10.1186/cc13046.
2
Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis.全血中HLA-DRA基因表达的定量实时聚合酶链反应测量具有高度可重复性,并显示出反映脓毒症病程中单核细胞表面HLA-DR表达动态变化的改变。
PLoS One. 2016 May 4;11(5):e0154690. doi: 10.1371/journal.pone.0154690. eCollection 2016.
3
Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?人类白细胞抗原(HLA - DR)基因表达在脓毒症中降低,且与肿瘤坏死因子α(TNFα)反应受损相关:一种免疫抑制的诊断工具?
PLoS One. 2017 Aug 3;12(8):e0182427. doi: 10.1371/journal.pone.0182427. eCollection 2017.
4
Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.脓毒性休克患者全血中主要组织相容性复合体II类基因的信使核糖核酸表达
Crit Care Med. 2005 Jan;33(1):31-8; discussion 236-7. doi: 10.1097/01.ccm.0000150958.20209.a3.
5
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma.单核细胞人白细胞抗原-DR 表达缺失与重大创伤后脓毒症的发生发展独立相关。
Crit Care. 2010;14(6):R208. doi: 10.1186/cc9331. Epub 2010 Nov 19.
6
Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.严重烧伤后单核细胞人类白细胞抗原-DR表达降低:与严重程度及继发性脓毒性休克的相关性
Crit Care Med. 2007 Aug;35(8):1910-7. doi: 10.1097/01.CCM.0000275271.77350.B6.
7
Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit.在一家儿科三级重症监护病房中,单核细胞人类白细胞抗原-DR表达的长期抑制与儿科脓毒症患者的死亡率相关。
J Crit Care. 2016 Jun;33:84-9. doi: 10.1016/j.jcrc.2016.01.027. Epub 2016 Feb 10.
8
Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock.人类白细胞抗原-DR抗原相关恒定链(CD74)信使核糖核酸表达降低预示着感染性休克后的死亡率。
Crit Care. 2013 Dec 10;17(6):R287. doi: 10.1186/cc13150.
9
Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.低单核细胞人白细胞抗原-DR 与脓毒性休克后医院感染独立相关。
Intensive Care Med. 2010 Nov;36(11):1859-66. doi: 10.1007/s00134-010-1962-x. Epub 2010 Jul 23.
10
Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock.脓毒症休克期间皮质醇对人单核细胞人类白细胞抗原-DR的转录下调作用
Am J Respir Crit Care Med. 2004 May 15;169(10):1144-51. doi: 10.1164/rccm.200309-1329OC. Epub 2004 Mar 17.

引用本文的文献

1
The blood transcriptional response in patients developing intensive care unit-acquired pneumonia.发生重症监护病房获得性肺炎患者的血液转录反应。
Eur Respir J. 2025 Apr 24;65(4). doi: 10.1183/13993003.00592-2024. Print 2025 Apr.
2
Pediatric Sepsis - Sailing the Unchartered Waters with Omics.小儿脓毒症——借助组学探索未知领域
Indian J Crit Care Med. 2024 Sep;28(9):818-819. doi: 10.5005/jp-journals-10071-24799. Epub 2024 Aug 31.
3
Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis.

本文引用的文献

1
Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?免疫疗法辅助治疗脓毒症:从免疫抑制到免疫刺激。是否需要改变范式?
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1287-93. doi: 10.1164/rccm.201301-0036CP.
2
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.脓毒症中的免疫抑制:对该疾病的新认识和新的治疗方法。
Lancet Infect Dis. 2013 Mar;13(3):260-8. doi: 10.1016/S1473-3099(13)70001-X.
3
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
通过综合生物信息学分析探索脓毒症的生物标志物和潜在治疗药物。
BMC Infect Dis. 2024 Jan 2;24(1):32. doi: 10.1186/s12879-023-08883-9.
4
The non-canonical inflammasome activators Caspase-4 and Caspase-5 are differentially regulated during immunosuppression-associated organ damage.非经典炎性小体激活物 Caspase-4 和 Caspase-5 在免疫抑制相关的器官损伤过程中受到差异调控。
Front Immunol. 2023 Dec 1;14:1239474. doi: 10.3389/fimmu.2023.1239474. eCollection 2023.
5
The Role of Transcriptomics in Redefining Critical Illness.转录组学在重新定义危重病中的作用。
Crit Care. 2023 Mar 21;27(1):89. doi: 10.1186/s13054-023-04364-2.
6
Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19.单核细胞 HLA-DR 表达在急性胰腺炎和 COVID-19 的免疫反应中的作用。
Int J Mol Sci. 2023 Feb 7;24(4):3246. doi: 10.3390/ijms24043246.
7
Cellular Immuno-Profile in Septic Human Host: A Scoping Review.脓毒症人类宿主的细胞免疫图谱:一项范围综述
Biology (Basel). 2022 Nov 7;11(11):1626. doi: 10.3390/biology11111626.
8
Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults.整合宿主-微生物血浆宏基因组学用于危重症成年患者脓毒症的前瞻性队列诊断。
Nat Microbiol. 2022 Nov;7(11):1805-1816. doi: 10.1038/s41564-022-01237-2. Epub 2022 Oct 20.
9
Precision medicine in sepsis and septic shock: From omics to clinical tools.脓毒症和脓毒性休克中的精准医学:从组学到临床工具。
World J Crit Care Med. 2022 Jan 9;11(1):1-21. doi: 10.5492/wjccm.v11.i1.1.
10
Disruption of Kidney-Immune System Crosstalk in Sepsis with Acute Kidney Injury: Lessons Learned from Animal Models and Their Application to Human Health.脓毒症合并急性肾损伤时肾脏与免疫系统相互作用的破坏:从动物模型中获得的经验教训及其对人类健康的应用
Int J Mol Sci. 2022 Feb 1;23(3):1702. doi: 10.3390/ijms23031702.
拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
4
Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.在体人免疫麻痹的逆转:一项双盲、安慰剂对照、随机先导研究。
Am J Respir Crit Care Med. 2012 Nov 1;186(9):838-45. doi: 10.1164/rccm.201204-0645OC. Epub 2012 Jul 19.
5
Drotrecogin alfa (activated) in adults with septic shock.活化的人重组凝血因子 VII 治疗成人感染性休克。
N Engl J Med. 2012 May 31;366(22):2055-64. doi: 10.1056/NEJMoa1202290. Epub 2012 May 22.
6
Immunosuppression in patients who die of sepsis and multiple organ failure.死于脓毒症和多器官衰竭的患者的免疫抑制。
JAMA. 2011 Dec 21;306(23):2594-605. doi: 10.1001/jama.2011.1829.
7
Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions.临床综述:重症监护病房中的流式细胞术观点——从感染诊断到损伤诱导的免疫功能障碍监测。
Crit Care. 2011;15(5):231. doi: 10.1186/cc10333. Epub 2011 Oct 7.
8
The late phase of sepsis is characterized by an increased microbiological burden and death rate.脓毒症的晚期阶段以微生物负担增加和死亡率升高为特征。
Crit Care. 2011 Jul 28;15(4):R183. doi: 10.1186/cc10332.
9
Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.低单核细胞人白细胞抗原-DR 与脓毒性休克后医院感染独立相关。
Intensive Care Med. 2010 Nov;36(11):1859-66. doi: 10.1007/s00134-010-1962-x. Epub 2010 Jul 23.
10
Immunotherapy for sepsis--a new approach against an ancient foe.脓毒症的免疫疗法——对抗古老敌人的新方法。
N Engl J Med. 2010 Jul 1;363(1):87-9. doi: 10.1056/NEJMcibr1004371.